Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Altered cells may suppress normal repair through an above a

Altered cells may secrete , an that suppresses normal neighbours’ , creating a for scheduling. An advantage unchanged across starting fractions and retained after switching off Notum would reject this mechanism

Stage of verification

  1. Hypothesis published2026-10-06
  2. Indirect evidenceAssessed at 5 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionGut and microbiome

Biological function

The biological function description is being prepared

Direction

A double ring marks the main placement where a group contains several values.

Lens
Frequency dependent secretory competition
Goal
Устойчивый запас до обращения пользы миметика во вред
Competing hypotheses
3
Published
2026-10-06
As a hypothesis
8 / 10Clarity of mechanism
8 / 10Few extra conditions
10 / 10Completeness of the answer
5 / 10Novelty of the idea
7 / 10Few new entities
8 / 10Decisive experiment
3 / 10Silver-bullet potential
5 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Enzyme

    A secreted that suppresses -dependent recovery of neighboring cells

    Where this hypothesis actsSecreted by altered cells during a pulse coinciding with feeding

    Hypotheses on this target 1
    NOTUMInhibition. Hypotheses on this target 11Activation. Hypotheses on this target 0Lower level. Hypotheses on this target 0Higher level. Hypotheses on this target 0Replacement. Hypotheses on this target 0Protection from degradation. Hypotheses on this target 0Cofactor removal. Hypotheses on this target 0Synthesis suppression. Hypotheses on this target 0Function preservation. Hypotheses on this target 0
    • Inhibition1
    • Activation
    • Lower level
    • Higher level
    • Replacement
    • Protection from degradation
    • Cofactor removal
    • Synthesis suppression
    • Function preservation

    What is proposed

    Inhibition

    Suppress for a limited time

    With whatControlled genetic model

    HowTime-limited suppression combined with an mimetic; genetic Notum inactivation tests the mechanism

    Possible result

    Possible loss of the threshold-dependent competitive advantage while preserving normal-cell

    From the recordПроверяемый кандидат сочетает миметик аутофагии с ограниченным по времени подавлением NOTUM.

  2. Harmful clone

    -altered cells

    Cells carrying an alteration in , compared with normal cells in the proposed experiments

    Where this hypothesis actsMixtures of normal and -altered , with validation in

    Hypotheses on this target 1
    APC-altered cellsClearance restoration. Hypotheses on this target 0Elimination. Hypotheses on this target 11Immunosuppression. Hypotheses on this target 0Population balance. Hypotheses on this target 0
    • Clearance restoration
    • Elimination1
    • Immunosuppression
    • Population balance

    What is proposed

    Elimination

    Remove some altered cells early when their local fraction is below the threshold

    With whatChange of environment or regimen

    HowAdvance immune removal relative to feeding and mimetic exposure while keeping the total dose unchanged

    Possible result

    Possible recovery of normal cells and a different response to the next mimetic pulse

    From the recordНиже порога раннее удаление части изменённых клеток позволяет нормальным клеткам восстановиться

  3. Metabolism and energy

    The cellular process of breaking down and recycling damaged components

    Where this hypothesis actsNormal cells exposed to the mimetic alongside altered cells

    Hypotheses on this target 2
    AutophagyInhibition. Hypotheses on this target 0Activation. Hypotheses on this target 11Function preservation. Hypotheses on this target 11Supplementation. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Direct measurement. Hypotheses on this target 0
    • Inhibition
    • Activation1
    • Function preservation1
    • Supplementation
    • Feedback restoration
    • Direct measurement

    What is proposed

    Activation

    Stimulate while limiting -mediated competition

    With whatSmall molecule

    HowUse an mimetic together with time-limited suppression

    Possible result

    Possible retention of the normal-cell autophagic response without the threshold-dependent clonal advantage

    From the recordПроверяемый кандидат сочетает миметик аутофагии с ограниченным по времени подавлением NOTUM.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKαNOTUM. Hypotheses on this target 1NOTUM
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cellsAPC-altered cells. Hypotheses on this target 1APC-altered cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionAutophagy. Hypotheses on this target 2Autophagy
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

A treatment intended to help cells clear damaged material could also help altered cells displace healthy neighbours. The unexpected move is to propose that the outcome depends on the altered cells’ local share of the population, so changing treatment timing alone may stop protecting normal cells above a threshold. This is a proposal generated by the pipeline, not a measured result: it pairs a treatment that imitates cellular cleanup with temporary suppression of , an released by cells that can inhibit signals supporting their neighbours.

The proposed mechanism, link by link
  1. A pulse coinciding with feeding is proposed to increase release from altered cells.
  2. Released is proposed to weaken supporting normal neighbours.
  3. Reduced renewal of normal neighbours is proposed to give altered cells a competitive advantage.
  4. Above a proposed , that advantage persists across the immune-timing shifts considered; below it, early removal of altered cells permits normal-cell recovery.
  5. Recovery of normal cells changes the population facing the next pulse, allowing the same total dose to produce a different outcome.
  6. Temporary suppression is proposed to prevent this competitive advantage while retaining the normal cells’ response.
A picture for it

Imagine weeds releasing something that slows nearby seedlings: removing a few weeds might let seedlings recover in a lightly invaded patch, while the same removal leaves a crowded patch dominated by weeds.

Where the picture breaks: The picture does not establish that a sharp threshold exists, that changes release, or that temporary suppression preserves cellular cleanup. Those are separate claims requiring measurement.

  1. Master questionstep 01 of 04

    Imitating useful processes already performed by the body might produce treatments that extend life.

    Rests on: The goal is to propose processes worth reproducing, interventions that might reproduce them, and reasons those effects could extend life.

    Assumption

    The starting premise is that reproducing selected beneficial processes could extend life. The supplied material does not establish a lifespan benefit for the proposed intervention.

  2. Goal pillarstep 02 of 04

    A useful treatment needs a durable margin before its benefits turn into harm.

    Rests on: The master question seeks life extension through imitation of useful bodily processes; this stage adds a requirement that benefit remain separated from harm.

    Assumption

    The chain assumes that a durable margin between benefit and harm is an appropriate criterion for selecting such treatments. It supplies no measure or boundary for that margin.

  3. Gap questionstep 03 of 04

    Changing when feeding, tissue repair and immune removal occur might preserve , the cellular process that breaks down and recycles internal material, without favouring the descendants of altered cells during treatment with a , a member of the chemical family that includes .

    Rests on: The previous stage requires a margin between benefit and harm. This stage chooses cellular cleanup as the benefit, altered-cell selection as the harm, and timing at equal total exposure as the possible separator.

    Leap

    The previous stage does not supply the connection to or explain why timing should separate cleanup from altered-cell selection. The screened sources do not establish that separation at equal total exposure.

  4. Hypothesisstep 04 of 04

    A brief exposure to , the selected for the proposal, is predicted to increase release from altered cells when it coincides with feeding. would suppress , messages between cells that support normal-cell renewal, giving altered cells an advantage that persists above a despite changes in immune timing within the range considered. Below the threshold, early removal of altered cells would allow normal neighbours to recover.S1

    Rests on: The preceding question supplies the timing problem. S1, published in Nature in 2021, reports that cells with an altered gene release and reduce the of normal , the cells that replenish the intestinal lining; it does not establish effects of , feeding or immune timing, or a . The endpoint adds those proposed links and a mathematical model in which relative growth depends on the mixture of neighbours.

    Supported by literature

What is carried, and what is not. Of the six mechanism links above, S1 directly supports the core of two: weakening signals that support normal cells, and reduced normal-cell renewal favouring altered cells, in an intestinal setting reported in Nature in 2021; it does not establish the proposed treatment sequence. S3, available here only as a Gut 2023 abstract, reports effects independent of in the cancer settings it examined, limiting generalisation of the proposed route; no supplied source establishes the sequence end to end.S1S3

Where the reasoning is carried by something unstated · 3
  • Master question. The starting premise is that reproducing selected beneficial processes could extend life. The supplied material does not establish a lifespan benefit for the proposed intervention.
  • Goal pillar. The chain assumes that a durable margin between benefit and harm is an appropriate criterion for selecting such treatments. It supplies no measure or boundary for that margin.
  • Gap question. The previous stage does not supply the connection to or explain why timing should separate cleanup from altered-cell selection. The screened sources do not establish that separation at equal total exposure. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • An increase in the altered cells’ share could be read as their growth even if their number stays constant while normal cells disappear. What closes it: The proposed accounting of absolute numbers must accompany population shares, with divisions, deaths and departures measured for both cell types. Restoration of normal-cell renewal must be distinguished from simply reducing altered-cell numbers.
  • Different outcomes at different starting shares could be attributed to a threshold even if another proposed route drives them, such as preferential immune removal of normal cells, different persistence of cleanup and growth effects, or failed preparation for copying genetic material. What closes it: The comparison with Notum genetically disabled must establish whether the starting-share threshold and its interaction with timing disappear, while checking that production was removed and normal-cell cleanup remains. The predicted increase in during coincident exposure and feeding also requires direct measurement.
  • A threshold measured in a thoroughly mixed culture could be mistaken for a threshold in tissue, where each cell encounters a particular local neighbourhood. What closes it: The proposed mixtures of , laboratory-grown three-dimensional tissue models, must distinguish overall altered-cell share from local share and arrangement. The specified repeat in , tissue containing neighbouring populations of different cell types, is needed to assess whether the same relationship survives local organisation.

What would make this wrong. The endpoint explicitly rejects its mechanism if altered cells retain the same advantage across different starting shares and that advantage persists after verified disabling of Notum. Failure to find the required internal threshold would also break the threshold-based explanation, even if still affected competition.

What it would change. If the hypothesis held, developing life-extending treatments that imitate cellular cleanup would require attention to the local composition of tissue as well as total dose and timing. Temporary suppression would become a candidate way to preserve normal competitors while retaining cleanup. Even a successful test in the proposed tissue models would not establish longer life, lasting cancer prevention, or a safe treatment schedule in humans.

Sources read · 7

4 literature searches, 4 full texts, 3 abstract-only; 7 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Partly answers it

NOTUM from Apc-mutant cells biases clonal competition to initiate cancer. · Nature · 2021

“Apc -mutant cells act as super-competitors and secrete Notum to attenuate the Wnt-rich stem cell niche, thereby outcompeting wild-type ISCs from the intestinal crypt by reducing their self-renewal.”

Does not settle: Источник оставляет открытыми влияние спермидина, питания и иммунного пика, порог локальной доли изменённых клеток, зависимость результата от времени и суммарной дозы импульсов, а также эффективность сочетания миметика аутофагии с ограниченным по времени подавлением NOTUM.

S2Partly answers it

USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer. · Oncogene · 2024

“Loss of USP10 reduced NOTUM signalling [ , ], a prerequisite for competitive tumour cell growth, and prevented tumour engraftment and growth in vivo.”

Does not settle: Источник связывает сигнализацию NOTUM с конкурентным ростом опухолевых клеток, но не устанавливает подавление восстановления нормальных соседних клеток, порог локальной доли изменённых клеток, влияние спермидина, питания или иммунного пика, зависимость результата от времени и суммарной дозы, а также эффективность сочетания миметика аутофагии с временным подавлением NOTUM.

S3Contradicts itAbstract only

APC and P53 mutations synergise to create a therapeutic vulnerability to NOTUM inhibition in advanced colorectal cancer. · Gut · 2023

“These phenotypes are Wnt-independent, resulting from differential activity of NOTUM on glypican 1 and 4 in early-stage versus late-stage disease, respectively.”

Does not settle: Открытыми остаются влияние спермидина и питания на продукцию NOTUM, подавление восстановления нормальных соседних клеток, порог локальной доли изменённых клеток, роль времени иммунного пика и эффективность сочетания миметика аутофагии с кратковременным подавлением NOTUM.

S4Background

Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways. · Biological research · 2019

“Notum, a secreted protein, was reported to deacylate various Wnt proteins leading to the inhibition of both canonical and non-canonical pathways simultaneously [ , ].”

Does not settle: Источник не исследует спермидин или его миметики, связь импульса с питанием, конкуренцию изменённых и нормальных клеток, локальный порог доли изменённых клеток, иммунный пик, восстановление нормальных соседей, суммарную дозу либо сочетание миметика аутофагии с временным подавлением NOTUM. Работа рассматривает хроническую инфекцию вирусом гепатита B, клетки Hep AD38 и LX-2, фиброз печени и сигнальный путь Wnt 5a.

S5BackgroundAbstract only

Inhibition of increases in ornithine decarboxylase and putrescine has no effect on rat liver regeneration. · The American journal of physiology · 1992

“However, despite ODC inhibition and substantially lower levels of putrescine, the course of liver regeneration in rats treated with DFMO was not affected.”

Does not settle: Открытыми остаются эффекты спермидинового миметика, роль секретируемого фермента NOTUM, конкуренция изменённых и нормальных клеток, порог локальной доли изменённых клеток, связь импульса с питанием, иммунный сдвиг и временное подавление NOTUM.

S6BackgroundAbstract only

Effect of combined alanine and glutamine administration on the inhibition of liver regeneration caused by long-term administration of alcohol. · Alcohol and alcoholism (Oxford, Oxfordshire). Supplement · 1994

“The results suggest that treatment with alanine and glutamine can help to prevent the inhibition of liver regeneration caused by alcohol by maintaining the spermine level and suppressing the acetylation of spermidine.”

Does not settle: The source does not examine spermidine pulses, feeding timing, altered-cell abundance, NOTUM secretion or inhibition, WNT-dependent repair, immune-peak timing, frequency-dependent competition, an abundance threshold, or combined autophagy mimetic and time-limited NOTUM suppression.

S7Background

The lncRNA GAS5-encoded micropeptide facilitates influenza virus replication through modulation of the Wnt/β-catenin signaling pathway. · Current research in microbial sciences · 2026

“Mechanistically, GAS5-P50 interacted with NOTUM, a negative regulator of Wnt signaling, leading to enhanced Wnt/β-catenin pathway activation, which facilitated viral replication.”

Does not settle: Источник не исследует спермидин, конкуренцию изменённых и нормальных клеток, секрецию NOTUM, порог локальной доли клеток, восстановление тканей, сдвиг иммунного пика, интервалы между введением и питанием или сочетание миметика аутофагии с временным подавлением NOTUM.

The gap this hypothesis explains

Can timing a -like treatment preserve cellular recycling benefits without favoring particular cell families at equal total exposure?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Можно ли разделить аутофагическую пользу и при действии , изменяя взаимное время питания, и при одинаковом суммарном воздействии?

What this question is asking

The question asks whether changing a treatment’s timing can separate a helpful effect on cellular recycling from an effect that favors some cell families over others. The treatment is a mimetic, a substance intended to imitate effects of compounds called . The proposed comparison keeps total treatment exposure equal while changing when treatment occurs relative to feeding, tissue rebuilding, and cell removal by the immune system. The question assumes that this treatment produces both a cellular recycling benefit and selection among cell families, but the supplied material does not establish either effect or identify the organism, treatment, or measurements.

What the terms mean
Polyamines
A class of compounds found in cells. The question names this class as the reference for a treatment but specifies no individual compound or particular effect to be imitated.
Polyamine mimetic
A substance intended to imitate some effects of . The label describes an intended resemblance, not proof that it reproduces every effect of those compounds.
Autophagy
Processes through which cells break down and recycle their own material. An autophagic benefit means a beneficial consequence attributed to those processes; increased recycling alone does not define the benefit, and the supplied material gives no measure of it.
Clone or cell family
A group of cells descended from one starting cell. The question concerns whether treatment favors some such groups over others, without identifying which groups.
Clonal selection
Preferential survival or expansion of particular cell families compared with others. The term describes a change in the cell population and does not by itself establish whether that change is helpful or harmful.
Regeneration
Rebuilding or replacing tissue. The question treats the timing of this process as potentially relevant to the treatment’s effects.
Immune clearance
Removal of cells by the immune system, the body’s system for recognizing and responding to threats. The question does not specify which cells are removed or how the timing of removal is determined.
Cumulative exposure
The total exposure to treatment over the period being compared. Keeping this equal is intended to distinguish timing effects from differences in overall exposure, but the question does not define how that total is calculated.
Physiological processes
Processes through which living bodies function. The broader request concerns imitating such processes to extend life, but it supplies no evidence that this particular treatment would do so.
What the question takes for granted
Premise could not be checked
A mimetic produces an autophagic benefit and clonal selection that might be separated by changing timing relative to feeding, regeneration, and immune clearance at equal cumulative exposure.

The assumption concerns a treatment that imitates , cellular machinery that breaks down and recycles material, and groups of cells descended from individual starting cells. It assumes the treatment improves recycling while favoring some of those groups, creating two effects whose dependence on timing can be compared. Establishing both effects would give the proposed separation a concrete meaning.

No screened sources were supplied. There is therefore no read evidence establishing either treatment effect, their relationship, or the role of timing; this does not show that the assumption is false.

The same question asked without the part nothing read establishes:

  • At equal total exposure, does changing a -like treatment’s timing relative to feeding, tissue rebuilding, and immune cell removal change cellular recycling benefits and the relative growth or survival of cell families?
  • Does a -like treatment produce both beneficial cellular recycling and preferential growth or survival of particular cell families?
What turns on the answer
  • Timing separates the effects At equal total exposure, one schedule would preserve the recycling benefit while reducing or avoiding preferential survival or expansion of particular cell families. Within the question’s framing, the timing of exposure would therefore determine whether these effects occur together; that result alone would not establish longer life.
  • The effects remain linked Schedules that preserve the recycling benefit would also retain selection among cell families. Changing timing would then fail to provide the proposed separation within the conditions compared, and the recycling result would still need to be understood alongside the population change.
  • The assumed pair of effects is absent If the treatment does not produce a recycling benefit or does not favor particular cell families, there would be no demonstrated pair of effects to separate. A difference between schedules would then answer a narrower question about whichever effect actually occurs.
Why it matters

The broader context is whether imitating physiological processes could help extend life. Under the question’s proposed mechanism, treatment would improve recycling within cells while also changing which cell families survive or expand. If timing separated these effects, the recycling benefit would not necessarily require the same change in the cell population. If it did not, treating improved recycling as sufficient evidence of an overall benefit could overlook changes in that population; the supplied material does not establish whether those changes would be harmful or affect lifespan.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Разделимость пользы и патологического отбора определяется через . Предполагается, что , совпавший с питанием, усиливает продукцию изменёнными клетками; подавляет зависимое от сигналов восстановление нормальных соседей. Выше определённой локальной доли изменённых клеток это преимущество сохраняется при любом сдвиге в рассматриваемом диапазоне. Ниже порога раннее удаление части изменённых клеток позволяет нормальным клеткам восстановиться, и следующий импульс уже даёт иной результат при той же . Поэтому универсального безопасного интервала между и питанием здесь нет: для стабилизации SPV_9 требуется удерживать ниже порога. Проверяемый кандидат сочетает с ограниченным по времени подавлением .

Where the idea comes from

The hypothesis borrows a result from another field. This is what it borrows, and from where.

, Тейлора и Джонкера: dx/dt = x(1-x)(f_M-f_N). Здесь t означает время в сутках; N_M и N_N означают абсолютное число изменённых и нормальных клеток в наблюдаемом участке; x = N_M/(N_M+N_N). типа i задаётся как f_i = a_iM(t)x + a_iN(t)(1-x), где i принимает значения M или N. Каждый коэффициент a_ij(t), в сутки⁻¹, оценивается по делениям, гибели и выходу клеток типа i из наблюдаемой популяции при преобладании соседей типа j в данной фазе питания, действия миметика и . Для абсолютных чисел дополнительно используют dN_i/dt = N_i f_i. сопоставляют при активном и выключенном . Гипотеза требует внутреннего порога x*, удовлетворяющего f_M(x*,t)=f_N(x*,t), с усилением преимущества M выше порога в регенеративной фазе; наличие порога предстоит установить. Равенство само по себе не делает одинаковыми x и фазовых коэффициентов. [Исходная модель](https://public.ek-cer.hu/~szabo/EGT20/library/taylor_mbs78.pdf).

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

При одинаковом расписании и одинаковой общей плотности клеток знак изменения доли изменённого будет зависеть от его исходной локальной доли. Перестановка фаз питания и удаления даст разные результаты по разные стороны измеренного порога. Notum в изменённых клетках устранит этот порог и соответствующее , сохранив нормальных клеток. Если преимущество одинаково при разных долях и сохраняется после выключения Notum, предложенный механизм отвергается.

Would tell it apart from at least one rival. The prediction specifies observable dependence on initial local clone proportion, disappearance of the threshold and interaction after Notum knockout, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Можно сравнивать смеси нормальных и -изменённых с разными исходными долями при одинаковой плотности. Notum и перенос проверяют звено. Результат следует воспроизвести в , поскольку упрощает локальные взаимодействия.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

При одинаковом расписании и одинаковой общей плотности клеток знак изменения доли изменённого будет зависеть от его исходной локальной доли. Перестановка фаз питания и удаления даст разные результаты по разные стороны измеренного порога. Notum в изменённых клетках устранит этот порог и соответствующее , сохранив нормальных клеток. Если преимущество одинаково при разных долях и сохраняется после выключения Notum, предложенный механизм отвергается.

  • What would separate them

    Immune killing of normal regenerating cells may favor precancerous clone growth predicts: В старых мышах с нормальными и -изменёнными кишечными клетками совпадение , питания и сначала увеличит и гибель нормальных клеток, затем увеличит абсолютную численность изменённого . Краткая только в этом окне либо удаление соответствующих только у нормальных клеток уменьшит поздний абсолютный рост при сохранении . Перенос на другое окно такого эффекта не даст. Отсутствие преимущественной иммунной гибели нормальных клеток опровергнет центральное звено, даже если изменение расписания окажется полезным.

  • What would separate them

    Different protein lifetimes may separate spermidine-driven cell recycling from clonal growth predicts: После обнаружится интервал, в котором остаётся повышенным, а дополнительная активность уже исчезла. Возобновление питания в этом интервале сохранит функциональную пользу при меньшем абсолютном росте изменённых клеток даже в без и при выключенном Notum. Экспериментальное продление закроет интервал, а обратимое удаление перед формированием устранит сохраняющуюся аутофагическую пользу. Если белковые ответы затухают совместно либо изменение не меняет разделимость, гипотеза отвергается.

  • What would separate them

    Premature DNA copying may damage resting cells as they resume growth and favour altered clones predicts: Вредное совпадение фаз даст уменьшение количества связанного с перед первой , затем повреждения ДНК преимущественно в нормальных клетках, вышедших из . Эффект сохранится при выключенном Notum и отсутствии . Краткое продление обратимым воздействием на должно восстановить -7 и уменьшить последующее преимущество изменённого при сохранении . Для подтверждения требуется сопоставить завершённое число делений за весь цикл: простое подавление недостаточно. Если преимущество расписания сохраняется после выравнивания подготовки , это объяснение отвергается.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionWould tell it apart from at least one rivalTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.